- Axsome pushes back generic entry for narcolepsy drug until 2040Axsome Therapeutics has successfully delayed generic competition for its narcolepsy drug Sunosi until 2040. The company announced on Wednesday that it has reached a settlement with the last appli…Endpoints · 1mo ago↗ source
- FDA guides pharma on explaining unapproved drugs to payorsBiopharma companies preparing to launch the next practice-changing blockbusters want payors to know what's coming before they ultimately land an FDA approval. The trick is to do that without stretc…Endpoints · 1mo ago↗ source
- What it will take for more employer GLP-1 coverageLast week, Eli Lilly proclaimed that its weight loss shot and pill are now “covered for millions of Americans,” now that all three major pharmacy benefit managers have put the ...